Skip to main content
. 2021 Nov 5;11:770565. doi: 10.3389/fonc.2021.770565

Figure 7.

Figure 7

Validation in kidney renal clear cell carcinoma (KIRC) patients. (A) The real-time quantitative PCR (RT-qPCR) result of aquaporin 9 (AQP9) in patients of different KIRC stages. (B) Simple linear regression of AQP9 level according to the different stages. (C, D) Multiple immunohistochemistry (mIHC) result of AQP9, CD163, and CD8 in KIRC tumor tissue.